Search Prime Contracts

W15QKN21C0012

Definitive Contract

Overview

Government Description
COVID-19 VACCINE PRODUCTION
Awardee
Pfizer
Awarding Agency
ACC Picatinny (PICA) [DoD - USA - AMC - ACC]
Funding Agency
Communications Electronics Command (CECOM) [DoD - USA - AMC]
NAICS
325414 - Biological Product (except Diagnostic) Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
New York, NY 10017 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed
Related Opportunity
W15QKN21R0038
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 07/31/21 to 06/30/23 and the Potential Award value has decreased 2% from $11,520,561,500 to $11,285,134,096.
Sole Source This Definitive Contract was awarded sole source to Pfizer because delay in acquisition (typically due to disaster response) could result in financial or bodily injury (FAR 6.302-6).
Subcontracting Plan This Definitive Contract has an Individual Subcontract Plan. The Department of Defense has an overall small business subcontracting goal of 30%
Unrealized Backlog This Definitive Contract is complete with $175,000,000 of unfunded backlog unused.
Pfizer was awarded Definitive Contract W15QKN21C0012 (W15QKN-21-C-0012) for Covid-19 Vaccine Production worth up to $11,285,134,096 by Communications Electronics Command in December 2020. The contract has a duration of 2 years 6 months and was awarded full & open with NAICS 325414 and PSC 6505 via sole source acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $175,000,000, though the contract is complete, so backlog may not be realized.

DOD Announcements

Dec 2020: Pfizer Inc., New York, New York, was awarded a $2,010,000,000 firm-fixed-price contract for the production of vaccine BNT162b2 in support of the national emergency response to COVID-19.  Bids were solicited via the internet with one received.  Work will be performed in New York, New York, with an estimated completion date of Aug. 22, 2022.  Fiscal 2020 other procurement (Army) funds in the amount of $2,010,000,000 were obligated at the time of the award.  The U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity (W15QKN-21-C-0012). (Awarded Dec. 22, 2020)

Status
(Complete)

Last Modified 6/28/23
Period of Performance
12/22/20
Start Date
6/30/23
Current End Date
6/30/23
Potential End Date
100% Complete

Obligations and Backlog
$11.1B
Total Obligated
$11.1B
Current Award
$11.3B
Potential Award
98% Funded
$0.0
Funded Backlog
$175.0M
Total Backlog

Award Hierarchy

Definitive Contract

W15QKN21C0012

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to W15QKN21C0012

Transaction History

Modifications to W15QKN21C0012

People

Suggested agency contacts for W15QKN21C0012

Competition

Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Urgency
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Defense Program
None
DoD Claimant Code
All Others Not Identifiable To Any Other Procurement Program
IT Commercial Item Category
Not Applicable
Awardee UEI
MHBQULRMEEJ5
Awardee CAGE
86491
Agency Detail
Awarding Office
W15QKN W6QK ACC-PICA
Funding Office
W15GK8
Created By
padds.w15qkn@cs.army.mil
Last Modified By
sysorig.w15qkn@sa2100
Approved By
sysorig.w15qkn@sa2100

Legislative

Legislative Mandates
None Applicable
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Representative
Jerrold Nadler

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Research, Development, Test, and Evaluation, Army (021-2040) Department of Defense-Military Research and development contracts (25.5) $1,221,328,041 100%
Modified: 6/28/23